Cytokinetics | CYTK - Capitale Ordinario

Prezzo Delle Azioni
65.32
Cambio Giornaliero
-0.16 -0.24%
Mensile
4.70%
Annuale
61.56%
Q2 Previsione
63.92




Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Amgen USD 539M 1000K 2025-12
Arca Biopharma USD 48.72M 338K 2025-12
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cytokinetics USD 122.26M 145K 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 268.1M 2.03M 2025-09
Geron USD 638.36M 338K 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03